These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 23859203)

  • 1. Resistance mechanism to an uncompetitive inhibitor of a single-substrate, single-product enzyme: a study of Helicobacter pylori glutamate racemase.
    Keating TA
    Future Med Chem; 2013 Jul; 5(11):1203-14. PubMed ID: 23859203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyrazolopyrimidinediones are selective agents for Helicobacter pylori that suppress growth through inhibition of glutamate racemase (MurI).
    de Jonge BL; Kutschke A; Uria-Nickelsen M; Kamp HD; Mills SD
    Antimicrob Agents Chemother; 2009 Aug; 53(8):3331-6. PubMed ID: 19433553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of inhibitors of Helicobacter pylori glutamate racemase as selective antibacterial agents: incorporation of imidazoles onto a core pyrazolopyrimidinedione scaffold to improve bioavailabilty.
    Basarab GS; Hill P; Eyermann CJ; Gowravaram M; Käck H; Osimoni E
    Bioorg Med Chem Lett; 2012 Sep; 22(17):5600-7. PubMed ID: 22877632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploitation of structural and regulatory diversity in glutamate racemases.
    Lundqvist T; Fisher SL; Kern G; Folmer RH; Xue Y; Newton DT; Keating TA; Alm RA; de Jonge BL
    Nature; 2007 Jun; 447(7146):817-22. PubMed ID: 17568739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent and selective inhibitors of Helicobacter pylori glutamate racemase (MurI): pyridodiazepine amines.
    Geng B; Basarab G; Comita-Prevoir J; Gowravaram M; Hill P; Kiely A; Loch J; MacPherson L; Morningstar M; Mullen G; Osimboni E; Satz A; Eyermann C; Lundqvist T
    Bioorg Med Chem Lett; 2009 Feb; 19(3):930-6. PubMed ID: 19097892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revisiting the essentiality of glutamate racemase in Mycobacterium tuberculosis.
    Morayya S; Awasthy D; Yadav R; Ambady A; Sharma U
    Gene; 2015 Jan; 555(2):269-76. PubMed ID: 25447907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substrate-induced conformational changes in Bacillus subtilis glutamate racemase and their implications for drug discovery.
    Ruzheinikov SN; Taal MA; Sedelnikova SE; Baker PJ; Rice DW
    Structure; 2005 Nov; 13(11):1707-13. PubMed ID: 16271894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutamate Racemase Is the Primary Target of β-Chloro-d-Alanine in Mycobacterium tuberculosis.
    Prosser GA; Rodenburg A; Khoury H; de Chiara C; Howell S; Snijders AP; de Carvalho LP
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6091-9. PubMed ID: 27480853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyridodiazepine amines are selective therapeutic agents for helicobacter pylori by suppressing growth through inhibition of glutamate racemase but are predicted to require continuous elevated levels in plasma to achieve clinical efficacy.
    de Jonge BL; Kutschke A; Newman JV; Rooney MT; Yang W; Cederberg C
    Antimicrob Agents Chemother; 2015 Apr; 59(4):2337-42. PubMed ID: 25645840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of Helicobacter pylori glutamate racemase inhibitors as selective antibacterial agents: a novel pro-drug approach to increase exposure.
    Basarab GS; Hill PJ; Rastagar A; Webborn PJ
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4716-22. PubMed ID: 18640833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethambutol targets the glutamate racemase of Mycobacterium tuberculosis-an enzyme involved in peptidoglycan biosynthesis.
    Pawar A; Jha P; Konwar C; Chaudhry U; Chopra M; Saluja D
    Appl Microbiol Biotechnol; 2019 Jan; 103(2):843-851. PubMed ID: 30456576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exiguaquinol: a novel pentacyclic hydroquinone from Neopetrosia exigua that inhibits Helicobacter pylori MurI.
    de Almeida Leone P; Carroll AR; Towerzey L; King G; McArdle BM; Kern G; Fisher S; Hooper JN; Quinn RJ
    Org Lett; 2008 Jun; 10(12):2585-8. PubMed ID: 18489104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of DNA gyrase activity by Mycobacterium smegmatis MurI.
    Sengupta S; Nagaraja V
    FEMS Microbiol Lett; 2008 Feb; 279(1):40-7. PubMed ID: 18177305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutamate racemase from Mycobacterium tuberculosis inhibits DNA gyrase by affecting its DNA-binding.
    Sengupta S; Shah M; Nagaraja V
    Nucleic Acids Res; 2006; 34(19):5567-76. PubMed ID: 17020913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moonlighting function of glutamate racemase from Mycobacterium tuberculosis: racemization and DNA gyrase inhibition are two independent activities of the enzyme.
    Sengupta S; Ghosh S; Nagaraja V
    Microbiology (Reading); 2008 Sep; 154(Pt 9):2796-2803. PubMed ID: 18757813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure and mechanism of glutamate racemase from Aquifex pyrophilus.
    Hwang KY; Cho CS; Kim SS; Sung HC; Yu YG; Cho Y
    Nat Struct Biol; 1999 May; 6(5):422-6. PubMed ID: 10331867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theoretical analysis of the catalytic mechanism of Helicobacter pylori glutamate racemase.
    Mixcoha E; Garcia-Viloca M; Lluch JM; González-Lafont A
    J Phys Chem B; 2012 Oct; 116(41):12406-14. PubMed ID: 22984984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of glutamate racemase by substrate-product analogues.
    Pal M; Bearne SL
    Bioorg Med Chem Lett; 2014 Mar; 24(5):1432-6. PubMed ID: 24507924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico approach towards identification of potential inhibitors of Helicobacter pylori DapE.
    Mandal RS; Das S
    J Biomol Struct Dyn; 2015; 33(7):1460-73. PubMed ID: 25204745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoroquinolone resistance in Helicobacter pylori: role of mutations at position 87 and 91 of GyrA on the level of resistance and identification of a resistance conferring mutation in GyrB.
    Rimbara E; Noguchi N; Kawai T; Sasatsu M
    Helicobacter; 2012 Feb; 17(1):36-42. PubMed ID: 22221614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.